More questions than answers at Walgreen

|By:, SA News Editor

Walgreen (WAG) felt pressure on pharmacy margins during FQ3 (earnings, details) with third-party reimbursements lower.

Though the forecast for cost savings from the company's merger with Alliance Boots was pushed higher, visibility on the integration is still cloudy with key decisions still hanging in the balance. A potential tax inversion move tops the list.

Walgreen pulled its 2016 guidance and put investors into a waiting period until later this summer for more clarity.

WAG -2.2% premarket